CYTOSORBENTS CORPORATION Conversion of Stock, Shares Converted
CYTOSORBENTS CORPORATION (CTSO) reported Conversion of Stock, Shares Converted of 92.71 thousand shares for the 0-month period ending 2014-10-09, per its 10-K filed 2015-03-31.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2017-03-03
- 2014-10-09: Conversion of Stock, Shares Converted 0 month 92.71K shares.
- 2014-03-07: Conversion of Stock, Shares Converted 0 month 40.80M shares.
| Period end | Conversion of Stock, Shares Converted 0 month |
|---|---|
| 2014-10-09 | 92.71K shares 10-K · filed 2015-03-31 |
| 2014-03-07 | 40.80M shares 10-Q · filed 2014-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |